← Back to catalogue

ADVIA Centaur® DIG +B

FDA UDI

Class II (US FDA UDI)

by Siemens Healthcare Diagnostics

Identity

Trade Name
ADVIA Centaur® DIG +B FDA UDI
Generic Name
Digoxin therapeutic drug monitoring IVD, kit, chemiluminescent assay FDA UDI
Device Name
Digoxin - CENTAUR - RGT - 250 tests FDA UDI
Model / Reference
10322129 FDA UDI
Description
Digoxin - CENTAUR - RGT - 250 tests FDA UDI

Identifiers

Catalog Number
110772 FDA UDI
Primary DI / UDI-DI
00630414177427 FDA UDI
510(k) Number
K931213 FDA UDI
FDA Product Code
KXT FDA UDI
GMDN Term
Digoxin therapeutic drug monitoring IVD, kit, chemiluminescent assay FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.3320 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Digoxin therapeutic drug monitoring IVD, kit, chemiluminescent assay

ADVIA Centaur® DIG +B by Siemens Healthcare Diagnostics — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Digoxin therapeutic drug monitoring IVD, kit, chemiluminescent assay.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 39925cd5-55ab-4117-8d5b-a364d6c6b74e 37 fields · synced May 30, 2026